Eiko Lifesciences Limited has made a regulatory disclosure regarding the appointment of its internal auditor for the financial year 2026-27.
The Board of Directors of the company, at its meeting held on May 26, 2026, approved the appointment of M/s NP Rajput & Co as Internal Auditor for FY 2026-27. This appointment was made based on the recommendation of the company's Audit Committee.
The disclosure is made pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026.
Detailed Particulars of Appointment
| Particular | Details |
| Name of the Firm | M/s NP Rajput & Co |
| Reason for Appointment | Re-Appointment as Internal Auditor of the Company |
| Date of Appointment | May 26, 2026 |
| Term of Appointment | For the Financial Year 2026-27 |
| Qualification & Brief Profile | M/s NP Rajput & Co has wide experience in Income tax Compliances, GST compliances, Accounting, Internal Audit, GST audit as well as handling major audit assignments |
| Disclosure of relationship between Directors | None |
The communication was signed by Chintan Bharatbhai Doshi, Company Secretary (Membership No.: A36190) on behalf of Eiko Lifesciences Limited.